Key facts
- This page summarizes MCGRAW LAURIE's Form 4 filing for Augmedix, Inc..
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 15 Jul 2024, 21:58.
MCGRAW LAURIE - 13 Jul 2024 Form 4 Insider Report for Augmedix, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 13 Jul 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 15 Jul 2024, 21:58:52 UTC
- Prior SEC filing
- 17 Jul 2023
- Next SEC filing
- 04 Oct 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Todd Holvick, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
MCGRAW LAURIE filed Form 4 for Augmedix, Inc. on 15 Jul 2024.
Change
- Previous filing in this sequence was filed on 17 Jul 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AUGX
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +21,598
- Change %
- +41%
- Price
- Shares after
- 74,230
- Date
- 13 Jul 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AUGX
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -21,598
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 13 Jul 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 21,598
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
Footnote F2
On July 13, 2023 (the "Grant Date"), the reporting person was granted 21,598 RSUs which vested in full on the one-year anniversary of the Grant Date.